HRP20090513T1 - S-mirtazapine for the treatment of hot flush - Google Patents

S-mirtazapine for the treatment of hot flush

Info

Publication number
HRP20090513T1
HRP20090513T1 HR20090513T HRP20090513T HRP20090513T1 HR P20090513 T1 HRP20090513 T1 HR P20090513T1 HR 20090513 T HR20090513 T HR 20090513T HR P20090513 T HRP20090513 T HR P20090513T HR P20090513 T1 HRP20090513 T1 HR P20090513T1
Authority
HR
Croatia
Prior art keywords
mirtazapine
treatment
hot flush
hot
flush
Prior art date
Application number
HR20090513T
Other languages
English (en)
Croatian (hr)
Inventor
Bernardus Peeters B.W.M.M.
Egbert Peter Adang Anton
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090513(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20090513T1 publication Critical patent/HRP20090513T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
HR20090513T 2004-11-15 2009-09-25 S-mirtazapine for the treatment of hot flush HRP20090513T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
PCT/EP2005/055947 WO2006051111A1 (en) 2004-11-15 2005-11-14 S-mirtazapine for the treatment of hot flush

Publications (1)

Publication Number Publication Date
HRP20090513T1 true HRP20090513T1 (en) 2009-10-31

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090513T HRP20090513T1 (en) 2004-11-15 2009-09-25 S-mirtazapine for the treatment of hot flush

Country Status (31)

Country Link
US (4) US20070265245A1 (xx)
EP (1) EP1814555B1 (xx)
JP (1) JP2008519810A (xx)
KR (1) KR20070085470A (xx)
CN (2) CN102772414A (xx)
AR (1) AR053780A1 (xx)
AT (1) ATE439843T1 (xx)
AU (1) AU2005303778B2 (xx)
BR (1) BRPI0517818A2 (xx)
CA (1) CA2587283C (xx)
CY (1) CY1110538T1 (xx)
DE (1) DE602005016141D1 (xx)
DK (1) DK1814555T3 (xx)
ES (1) ES2329815T3 (xx)
HK (1) HK1104235A1 (xx)
HR (1) HRP20090513T1 (xx)
IL (1) IL182767A (xx)
MX (1) MX2007005827A (xx)
MY (1) MY144089A (xx)
NO (1) NO20072285L (xx)
NZ (1) NZ554858A (xx)
PE (1) PE20061051A1 (xx)
PL (1) PL1814555T3 (xx)
PT (1) PT1814555E (xx)
RS (1) RS51138B (xx)
RU (1) RU2396957C2 (xx)
SI (1) SI1814555T1 (xx)
TW (1) TW200631584A (xx)
UA (1) UA88655C2 (xx)
WO (1) WO2006051111A1 (xx)
ZA (1) ZA200703884B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002174A2 (en) * 2005-06-27 2007-01-04 N.V. Organon. A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
MX2008011434A (es) * 2006-03-06 2008-11-18 Organon Nv Metodo mejorado para retirar del tratamiento hormonal los sintomas vasomotores inducidos por eliminación de hormonas.
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
EP3261645B1 (en) 2015-02-27 2021-04-28 Dechra Limited Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
CA3065003A1 (en) * 2017-05-25 2018-11-29 Glytech, Llc Formulations for treatment of post-traumatic stress disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
ATE254918T1 (de) * 1998-04-02 2003-12-15 Akzo Nobel Nv Orale flüssige lösung enthaltend das antidepressivum mirtazapine

Also Published As

Publication number Publication date
IL182767A (en) 2011-07-31
IL182767A0 (en) 2007-09-20
CN101056641A (zh) 2007-10-17
ES2329815T3 (es) 2009-12-01
RU2007122391A (ru) 2008-12-20
EP1814555B1 (en) 2009-08-19
UA88655C2 (ru) 2009-11-10
SI1814555T1 (sl) 2009-12-31
PE20061051A1 (es) 2006-10-26
CA2587283C (en) 2013-01-15
TW200631584A (en) 2006-09-16
CA2587283A1 (en) 2006-05-18
MX2007005827A (es) 2007-07-20
AU2005303778B2 (en) 2011-02-17
AU2005303778A1 (en) 2006-05-18
RU2396957C2 (ru) 2010-08-20
DE602005016141D1 (de) 2009-10-01
WO2006051111A1 (en) 2006-05-18
NO20072285L (no) 2007-06-13
US20130225559A1 (en) 2013-08-29
US20070265245A1 (en) 2007-11-15
KR20070085470A (ko) 2007-08-27
PL1814555T3 (pl) 2010-01-29
RS51138B (sr) 2010-10-31
ATE439843T1 (de) 2009-09-15
JP2008519810A (ja) 2008-06-12
HK1104235A1 (en) 2008-01-11
US20100267694A1 (en) 2010-10-21
EP1814555A1 (en) 2007-08-08
CY1110538T1 (el) 2015-04-29
PT1814555E (pt) 2009-09-30
ZA200703884B (en) 2009-07-29
US20120302552A1 (en) 2012-11-29
BRPI0517818A2 (pt) 2010-03-16
CN102772414A (zh) 2012-11-14
NZ554858A (en) 2009-10-30
AR053780A1 (es) 2007-05-23
MY144089A (en) 2011-08-15
DK1814555T3 (da) 2009-12-07

Similar Documents

Publication Publication Date Title
HRP20090513T1 (en) S-mirtazapine for the treatment of hot flush
ATE461217T1 (de) Glp-1-verbindungen
TW200612918A (en) Lonidamine analogs
RS52601B (en) BENZOTIAZEPINE DERIVATIVES AS A RYANODIN (RYR2) RECEPTOR INHIBITOR AND THEIR USE IN THE TREATMENT OF HEART DISEASES
SG145699A1 (en) Pyridazine derivatives and their use as therapeutic agents
IS7858A (is) Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD)
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
MX2007002277A (es) Metodos para formar retinoides y usos de los mismos.
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
NO20055390D0 (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
UY28344A1 (es) Nuevos compuestos
ATE399532T1 (de) Medizinische seife
DE60326190D1 (de) des Körpers
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
RS52038B (en) USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS
IS8391A (is) Notkun á síramesíni við meðhöndlun á krabbameini
AU302730S (en) Bed
NO20062138L (no) Anvendelse av ifenprodil i behandling av smerte
DK1519732T3 (da) Anvendelse af inhibitorer af vasopeptidase til behandling af nefropati
EA200401037A1 (ru) Антифосфолипазный препарат
GB2407499B (en) Vitamin D3 analogue for use in the treatment of BPH
UA12150S (uk) Крісло м'яке
UA12148S (uk) Крісло м'яке